Skip to content

Kimberly Manhard, Director at Inhibrx Biosciences, sold INBX on Sep 15, 2026

Data as of Oct 16

▼ SELL$52.5K500 shares at $105.05Kimberly Manhard DirectorINBX Inhibrx Biosciences, Inc.
Watch INBX
Traded
Sep 15, 2026
Disclosed
Sep 15, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kimberly Manhard, Director at Inhibrx Biosciences, sold INBX on Sep 15, 2026TRADEDDISCLOSED
INBXSimilar stocks (XLV — its sector index fund), rebased to INBX's price on the disclosure day
INBX since disclosure
−14.9%
after the sale
Similar stocks (XLV) since disclosure
+5.4%
XLV — its sector index fund

Change in closing price from Sep 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKimberly Manhard DirectorINBX Inhibrx Biosciences, Inc.$55.1Kdisclosed Sep 15 · filed 1 day after the trade
  2. ▼ SELLKimberly Manhard DirectorINBX Inhibrx Biosciences, Inc.$55.9Kdisclosed Sep 15 · filed 4 days after the trade

See every trade on INBX →